NewMediaWire distributes press releases on behalf of hundreds of publicly traded companies, as well as private corporations, non-profits and other public sector organizations. Founded and staffed by industry veterans, we offer a full complement of services including specialized delivery to financial sites and posting of photos and multimedia content. In addition, NewMediawire offers international and specialized services such as IR websites and industry specific distribution.
November 9, 2026 — Research Highlights: In two, separate, year-long clinical trials, adults with moderate-to-severe sleep apnea and excess weight (BMI ≥27 kg/m²) who took the oral GLP-1 medication orforglipron, had about 18 fewer breathing interruptions per hour of sleep after 52 weeks, compared with about 5 fewer breathing interruptions per hour of sleep among people who took a placebo, respectively. Participants taking orforglipron also had greater reductions in cardiovascular risk factors, including body weight, high-sensitivity C-reactive protein (hs-CRP), a blood marker of inflammation, and systolic blood pressure after one year.
November 9, 2026 — BLOOMINGTON, MN - November 9, 2026 (NEWMEDIAWIRE) - Solar Energy Initiatives, Inc. (OTC: SNRY) today announced the successful completion of its acquisition of Alpha Incorporated, delivering the first major operating asset onto the platform and immediately unlocking access to Alpha’s established client base, active joint ventures, and capital-formation relationships.
November 9, 2026 — By Meg Flippin, Benzinga DETROIT, MICHIGAN - November 9, 2026 (NEWMEDIAWIRE) - When it comes to replacing fossil fuel boilers, the first question an industrial company often asks is how much it will save. BrenX Ltd.
November 9, 2026 — ATLANTA, GA - November 9, 2026 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced that the Company's Board of Directors has approved a reverse stock split of its issued and outstanding shares of common stock, par value $0.
November 9, 2026 — BEVERLY HILLS, CA - November 9, 2026 (NEWMEDIAWIRE) - BridgeCore Capital, Inc. announced the closing of $1,040,000 in acquisition financing for a three-property commercial real estate portfolio located in Hampton, Portsmouth, and Newport News, Virginia.
November 9, 2026 — - World of Spirits in the Spotlight and Chinese Wines and Baijiu Accelerate Global Expansion HONG KONG - November 9, 2026 (NEWMEDIAWIRE) - Organised by the Hong Kong Trade Development Council (HKTDC), the 18th Hong Kong International Wine & Spirits Fair concluded successfully yesterday. The three-day fair (5-7 November) attracted over 8,200 trade buyers from 66 countries and regions.
November 9, 2026 — - Smart Eyewear and Silver Economy Unlock New Opportunities Reinforcing Hong Kong's Gateway Role for Global Expansion HONG KONG - November 9, 2026 (NEWMEDIAWIRE) - The 34th Hong Kong International Optical Fair, organised by the Hong Kong Trade Development Council (HKTDC) and co-organised by the Hong Kong Optical Manufacturers Association (HKOMA), concluded successfully today. Under the theme "Bright Eyes • New Horizons", the three-day fair attracted some 12,000 buyers from 101 countries and regions.
November 8, 2026 — Research Highlights: A five-year, randomized controlled trial of 60 counties in North Carolina (representing a population of over 8. 5 million people) found that a comprehensive emergency medical services (EMS) and community-based cardiac arrest educational intervention did not significantly improve survival to hospital discharge with good brain function for adults who experienced cardiac arrest outside of a hospital.
November 8, 2026 — Research Highlights: In a randomized clinical trial of more than 300 adults, ages 55 years and older in China with high blood pressure who had an ablation procedure for atrial fibrillation, treatment with a combination of sacubitril and valsartan was associated with fewer recurring irregular heart rhythms than treatment with valsartan alone, after a 12-month follow-up period. Blood pressure decreased by similar amounts in both groups, suggesting the difference in recurring abnormal heart rhythms may not be explained by blood pressure reduction alone.
November 8, 2026 — Research Highlights: Left bundle branch pacing, a pacemaker technique that follows the heart’s natural electrical pathway, led to better outcomes for people with an implanted pacemaker compared to those with pacemakers with right ventricular pacing, the standard treatment for people with atrioventricular block, a condition also known as heart block, which is a type of heart rhythm disorder. The international, multicenter, clinical OptimPacing trial with nearly 700 adults found that people with pacemakers using left bundle branch pacing had fewer deaths, hospitalizations for heart failure and incidences of pacing-induced cardiomyopathy (weakened heart muscle) compared to people with pacemakers using right ventricular pacing.
November 8, 2026 — CHICAGO, IL - November 8, 2026 (NEWMEDIAWIRE) - With growing scientific evidence underscoring the close connection between heart and brain health, the American Heart Association Center for the Brain™ is being established to advance science, deepen understanding and help people live longer, healthier lives. The American Heart Association, a relentless force changing the future of health for everyone everywhere, is expanding its focus on brain health as an important part of overall wellness and longevity.
November 7, 2026 — Research Highlights: In a small feasibility study of 39 patients in England, physician responders used a minimally invasive procedure called Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) to try to improve blood flow to the heart and brain during out-of-hospital cardiac arrest. Several key measures of circulation improved during resuscitation: the lower blood pressure number (which is particularly important for restarting the heart during CPR) increased 62%, the upper number (an important determinant of blood flow to the brain) rose 20%, and carbon dioxide in exhaled breath, an important sign of effective circulation during CPR, increased 50%.
November 7, 2026 — Research Highlights: A study including nearly 3,500 adults in India with heart failure found that participants in a yoga-based cardiac rehabilitation program reported improved quality of life and walking distance compared to the group that received enhanced standard care. However, there was no statistically significant difference in the combined rate of death, hospitalization or stroke between the yoga-based cardiac rehab group and the enhanced standard care group.
November 7, 2026 — Research Highlights: Alerting nearby CPR-trained volunteers through a smartphone app did not increase the likelihood that a person experiencing cardiac arrest received CPR or use of an AED before professional responders arrived, according to a study conducted in British Columbia and Columbus, Ohio. Researchers randomly assigned cardiac arrest 911 calls to either standard EMS dispatch only or standard dispatch and PulsePoint Respond alerts to nearby first-responder volunteers, comparing response times of both.
November 7, 2026 — Research Highlights: Compared to standard treatment, using antihypertensive medications to lower systolic blood pressure (the top number in a reading) below 120 mm Hg in middle-aged adults with Type 2 diabetes did not significantly reduce the incidence of cardiovascular death, stroke, heart attack and other cardiovascular events. There is still a chance of a modest but clinically relevant benefit from more intensive blood pressure-lowering treatment, and high blood pressure management in people with Type 2 diabetes should remain individualized, researchers said.
November 7, 2026 — Research Highlights: Selecting which volunteer community first responders were alerted to the scene of a cardiac arrest was overall more successful when alerting responders who had shorter estimated arrival times than only sending out alerts to responders who were geographically closer to the scene and also reduced dispatching volunteers likely to get to the scene after EMS, according to preliminary research conducted by researchers in Freiburg, Germany. Because “smart” alerting considered obstacles related to how fast the responder could get to the scene, this method nearly doubled the chance of early volunteer arrival compared with alerts sent only to responders within the nearby geographical area.
November 7, 2026 — Research Highlights: In a study of almost 1,900 adults, ages 70 years and older who had other chronic health conditions but not cardiovascular disease, those who stopped taking cholesterol-lowering statins had similar rates of heart attack, stroke and death after two years when compared to peers who continued taking statins. There was an increase in the number of heart attacks and strokes among a small number of older adults who discontinued statins in an extended follow-up of up to four years, compared to peers who continued taking the medications.
November 7, 2026 — Research Highlights: Stroke and TIA survivors in Brazil who received medications to lower systolic blood pressure(the top number of a blood pressure reading) to less than 120 mm Hg were significantly less likely to die or have cardiovascular events within 4 years, compared to those who received standard treatment to lower levels below 140 mm Hg. During the four-year intervention of more than 4,000 people, more intensive blood pressure control reduced the risk of major cardiovascular events by about 21%, compared to standard treatment.
November 7, 2026 — Research Highlights: Adding the diuretic medication spironolactone to post-stroke care for adults with uncontrolled high blood pressure resulted in average systolic blood pressure (the top number) that was nearly 8 mm Hg lower at three months compared with usual post-stroke care. Spironolactone is a low-cost diuretic medication (or water pill) that helps the body excrete salt and water to prevent buildup, and it is usually added later in blood pressure treatment, typically when blood pressure stays high despite three other medications.
